Replies to post #142229 on Biotech Values

[DewDiligence]

If I recall correctly, the IP associated with therapeutic use of Apo A1 Milano still resides in the sub-basement of Pfizer as a result of the Esperion purchase?

It was licensed by MDCO in late 2009 (#msg-44863685).